Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis
Objective - Mutations in Fused in Sarcoma (FUS or TLS) are the fourth most prevalent in Western European familial amyotrophic lateral sclerosis (ALS) populations and have been associated with causing both early and very late disease onset. FUS aggregation, DNA repair deficiency, and genomic instabil...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019 Nov 4
|
| In: |
Annals of Clinical and Translational Neurology
Year: 2019, Volume: 6, Issue: 12, Pages: 2384-2394 |
| ISSN: | 2328-9503 |
| DOI: | 10.1002/acn3.50930 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/acn3.50930 Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917314/ 
|
| Author Notes: | Marcel Naumann, Kevin Peikert, Rene Günther, Anneke J. van der Kooi, Eleonora Aronica, Annemarie Hübers, Veronique Danel, Philippe Corcia, Francisco Pan‐Montojo, Sebahattin Cirak, Göknur Haliloglu, Albert C. Ludolph, Anand Goswami, Peter M. Andersen, Johannes Prudlo, Florian Wegner, Philip Van Damme, Jochen H. Weishaupt & Andreas Hermann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1760778931 | ||
| 003 | DE-627 | ||
| 005 | 20240414193204.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210617s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/acn3.50930 |2 doi | |
| 035 | |a (DE-627)1760778931 | ||
| 035 | |a (DE-599)KXP1760778931 | ||
| 035 | |a (OCoLC)1341416386 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Naumann, Marcel |e VerfasserIn |0 (DE-588)1235620387 |0 (DE-627)1760652881 |4 aut | |
| 245 | 1 | 0 | |a Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis |c Marcel Naumann, Kevin Peikert, Rene Günther, Anneke J. van der Kooi, Eleonora Aronica, Annemarie Hübers, Veronique Danel, Philippe Corcia, Francisco Pan‐Montojo, Sebahattin Cirak, Göknur Haliloglu, Albert C. Ludolph, Anand Goswami, Peter M. Andersen, Johannes Prudlo, Florian Wegner, Philip Van Damme, Jochen H. Weishaupt & Andreas Hermann |
| 264 | 1 | |c 2019 Nov 4 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.06.2021 | ||
| 520 | |a Objective - Mutations in Fused in Sarcoma (FUS or TLS) are the fourth most prevalent in Western European familial amyotrophic lateral sclerosis (ALS) populations and have been associated with causing both early and very late disease onset. FUS aggregation, DNA repair deficiency, and genomic instability are contributors to the pathophysiology of FUS‐ALS, but their clinical significance per se and their influence on the clinical variability have yet to be sufficiently investigated. The aim of this study was to analyze genotype-phenotype correlations and malignancy rates in a newly compiled FUS‐ALS cohort. - - Methods - We cross‐sectionally reviewed FUS‐ALS patient histories in a multicenter cohort with 36 novel cases and did a meta‐analysis of published FUS‐ALS cases reporting the largest genotype-phenotype correlation of FUS‐ALS. - - Results - The age of onset (median 39 years, range 11-80) was positively correlated with the disease duration. C‐terminal domain mutations were found in 90%. Among all, P525L and truncating/ frameshift mutations most frequently caused juvenile onset, rapid disease progression, and atypical ALS often associated with negative family history while the R521 mutation site was associated with late disease onset and pure spinal phenotype. Malignancies were found in one of 40 patients. - - Interpretation - We report the largest genotype-phenotype correlation of FUS‐ALS, which enables a careful prediction of the clinical course in newly diagnosed patients. In this cohort, FUS‐ALS patients did not have an increased risk for malignant diseases. | ||
| 700 | 1 | |a Peikert, Kevin |d 1990- |e VerfasserIn |0 (DE-588)1064645305 |0 (DE-627)813732115 |0 (DE-576)424002124 |4 aut | |
| 700 | 1 | |a Günther, Rene |e VerfasserIn |4 aut | |
| 700 | 1 | |a van der Kooi, Anneke J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aronica, Eleonora |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hübers, Annemarie |d 1982- |e VerfasserIn |0 (DE-588)133907732 |0 (DE-627)557961149 |0 (DE-576)300184840 |4 aut | |
| 700 | 1 | |a Danel, Veronique |e VerfasserIn |4 aut | |
| 700 | 1 | |a Corcia, Philippe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pan‐Montojo, Francisco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cirak, Sebahattin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haliloglu, Göknur |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ludolph, Albert C. |d 1953- |e VerfasserIn |0 (DE-588)1081317531 |0 (DE-627)845970100 |0 (DE-576)454116195 |4 aut | |
| 700 | 1 | |a Goswami, Anand |e VerfasserIn |4 aut | |
| 700 | 1 | |a Andersen, Peter M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Prudlo, Johannes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wegner, Florian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Damme, Philip |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weishaupt, Jochen H. |d 1971- |e VerfasserIn |0 (DE-588)122148924 |0 (DE-627)705789039 |0 (DE-576)293117810 |4 aut | |
| 700 | 1 | |a Hermann, Andreas |d 1978- |e VerfasserIn |0 (DE-588)132948664 |0 (DE-627)529181851 |0 (DE-576)339680652 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of Clinical and Translational Neurology |d Chichester [u.a.] : Wiley, 2013 |g 6(2019), 12, Seite 2384-2394 |h Online-Ressource |w (DE-627)77139649X |w (DE-600)2740696-9 |w (DE-576)396696678 |x 2328-9503 |7 nnas |a Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis |
| 773 | 1 | 8 | |g volume:6 |g year:2019 |g number:12 |g pages:2384-2394 |g extent:11 |a Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis |
| 856 | 4 | 0 | |u https://doi.org/10.1002/acn3.50930 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917314/ |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210617 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 122148924 |a Weishaupt, Jochen H. |m 122148924:Weishaupt, Jochen H. |p 18 | ||
| 999 | |a KXP-PPN1760778931 |e 3939126217 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 15.05.20"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2013 -"],"language":["eng"],"title":[{"title_sort":"Annals of Clinical and Translational Neurology","title":"Annals of Clinical and Translational Neurology"}],"recId":"77139649X","disp":"Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosisAnnals of Clinical and Translational Neurology","id":{"issn":["2328-9503"],"zdb":["2740696-9"],"eki":["77139649X"]},"origin":[{"publisherPlace":"Chichester [u.a.]","dateIssuedDisp":"2013-","publisher":"Wiley","dateIssuedKey":"2013"}],"part":{"text":"6(2019), 12, Seite 2384-2394","extent":"11","volume":"6","pages":"2384-2394","year":"2019","issue":"12"}}],"note":["Gesehen am 17.06.2021"],"id":{"doi":["10.1002/acn3.50930"],"eki":["1760778931"]},"origin":[{"dateIssuedDisp":"2019 Nov 4","dateIssuedKey":"2019"}],"name":{"displayForm":["Marcel Naumann, Kevin Peikert, Rene Günther, Anneke J. van der Kooi, Eleonora Aronica, Annemarie Hübers, Veronique Danel, Philippe Corcia, Francisco Pan‐Montojo, Sebahattin Cirak, Göknur Haliloglu, Albert C. Ludolph, Anand Goswami, Peter M. Andersen, Johannes Prudlo, Florian Wegner, Philip Van Damme, Jochen H. Weishaupt & Andreas Hermann"]},"recId":"1760778931","person":[{"given":"Marcel","role":"aut","family":"Naumann","display":"Naumann, Marcel"},{"role":"aut","given":"Kevin","family":"Peikert","display":"Peikert, Kevin"},{"family":"Günther","role":"aut","given":"Rene","display":"Günther, Rene"},{"display":"van der Kooi, Anneke J.","family":"van der Kooi","given":"Anneke J.","role":"aut"},{"family":"Aronica","given":"Eleonora","role":"aut","display":"Aronica, Eleonora"},{"display":"Hübers, Annemarie","family":"Hübers","role":"aut","given":"Annemarie"},{"display":"Danel, Veronique","family":"Danel","given":"Veronique","role":"aut"},{"display":"Corcia, Philippe","family":"Corcia","given":"Philippe","role":"aut"},{"display":"Pan‐Montojo, Francisco","family":"Pan‐Montojo","given":"Francisco","role":"aut"},{"display":"Cirak, Sebahattin","family":"Cirak","role":"aut","given":"Sebahattin"},{"family":"Haliloglu","given":"Göknur","role":"aut","display":"Haliloglu, Göknur"},{"family":"Ludolph","role":"aut","given":"Albert C.","display":"Ludolph, Albert C."},{"role":"aut","given":"Anand","family":"Goswami","display":"Goswami, Anand"},{"display":"Andersen, Peter M.","role":"aut","given":"Peter M.","family":"Andersen"},{"display":"Prudlo, Johannes","family":"Prudlo","role":"aut","given":"Johannes"},{"display":"Wegner, Florian","given":"Florian","role":"aut","family":"Wegner"},{"display":"Van Damme, Philip","family":"Van Damme","given":"Philip","role":"aut"},{"role":"aut","given":"Jochen H.","family":"Weishaupt","display":"Weishaupt, Jochen H."},{"given":"Andreas","role":"aut","family":"Hermann","display":"Hermann, Andreas"}],"title":[{"title":"Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis","title_sort":"Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis"}],"physDesc":[{"extent":"11 S."}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a NAUMANNMARPHENOTYPES2019 | ||